Shannon Wisniewski

Shannon Wisniewski has been working in the pharmaceutical industry since 2008. Shannon began their career at Sanofi Pasteur as a Research to Launch Technician in 2008. In 2009, they moved to ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company, as a Research Associate. In 2014, they became a Global Launch Project Manager at Eli Lilly and Company. In 2018, they took on the role of Project Manager at Clinical Genomics. Currently, they are the Director of Program Management at Starton Therapeutics.

Shannon Wisniewski graduated from York College of Pennsylvania with a Bachelor of Science degree.